MedTrace Logo

A Study to Evaluate the Safety and Effectiveness of a Nasal Spray to Treat Perennial Allergies

NCT00712920 · Status: COMPLETED · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 581

Last updated 2011-06-08

Study results available
· View outcomes & findings →

Summary

The purpose of this study is to determine if two allergy medications are more effective than placebo.

Conditions

  • Perennial Allergic Rhinitis

Interventions

DRUG

0.15% azelastine hydrochloride

0.15% azelastine hydrochloride 1644 mcg

DRUG

0.1% azelastine hydrochloride

0.1% azelastine hydrochloride 1096 mcg

DRUG

Placebo

Placebo

Sponsors & Collaborators

  • Meda Pharmaceuticals

    lead INDUSTRY

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
12 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2007-01-31
Primary Completion
2008-05-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Drugs

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00712920 on ClinicalTrials.gov